Famicordtx S.A.
- Address
- Ul Dzialkowa 85
Sponsor Overview
Specializations
Hematologic Oncology
Famicordtx S.A. focuses on blood cancers, with research centered on refractory and relapsed CD19+ B cell neoplasms.
- B cell neoplasms
- CD19-targeted therapy
- Refractory disease
- Relapsed malignancy
The sponsor’s clinical activity is concentrated in oncology settings where immune-based approaches are used for difficult-to-treat hematologic malignancies.
Cell Therapy
The sponsor’s research includes autologous CAR T-cell therapy, reflecting a therapeutic interest in engineered immune cells for cancer treatment.
- Autologous CAR T cells
- Cell-based immunotherapy
- Genetically modified lymphocytes
- Immune effector targeting
This area aligns with clinical development in personalized immunotherapy for patients with limited treatment options.
Immuno-Oncology
Famicordtx S.A. is engaged in immuno-oncology research aimed at redirecting the immune system against malignant B cells.
- Targeted immune activation
- Antigen-specific recognition
- Adoptive cell transfer
- Anti-tumor immune response
The sponsor’s work is concentrated on therapies designed to address immune-resistant cancers through cellular targeting strategies.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Autologous CAR T Cells (Tarcidomgen Kimleucel) in Refractory and Relapsed CD19+ B Cell Neoplasms | Poland | Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 2 sites across their trial portfolio.
Therapeutic Focus
- 1.Hemic and Lymphatic Diseases1 trial249 other sponsors
Partnered Research Centres
2 centres- Address
- Ul. Mariana Smoluchowskiego 17, 80-214 Gdansk
- Address
- Ul. Ulica Stefana Banacha 1a, 02-097 Warsaw
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Famicordtx S.A..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

